Japan Nuclear Medicine-Radiopharmaceuticals Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Nuclear Medicine-Radiopharmaceuticals market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Nuclear Medicine-Radiopharmaceuticals market. Detailed analysis of key players, along with key growth strategies adopted by Nuclear Medicine-Radiopharmaceuticals industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Immunomedics, Inc. (US)

    • Mallinckrodt Pharmaceuticals (Ireland)

    • Cardinal Health, Inc (US)

    • Peregrine Pharmaceuticals, Inc. (US)

    • Avid Radiopharmaceuticals (US)

    • Advanced Medical Isotope Corporation (US)

    • Alseres Pharmaceuticals, Inc (US)

    • Bracco Imaging S.p.A (Italy)

    • Bayer HealthCare Medical Care (US)

    • Ion Beam Applications S.A (Belgium)

    • GE Healthcare (UK)

    • Siemens Healthcare (US)

    • Jubilant Pharma (India)

    • Triad Isotopes, Inc. (US)

    • Alliance Medical (UK)

    • Nordion, Inc. (Canada)

    • Actinium Pharmaceuticals Inc (US)

    • Positron Corporation (US)

    • Medi-Radiopharma Ltd (Hungary)

    • Lantheus Medical Imaging Inc (US)


    By Type:

    • Diagnostic Medicine

    • Therapeutic Medicine


    By End-User:

    • SPECT

    • PET

    • Therapeutic


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine-Radiopharmaceuticals Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Medicine from 2014 to 2026

      • 1.3.2 Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Medicine from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of SPECT from 2014 to 2026

      • 1.4.2 Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of PET from 2014 to 2026

      • 1.4.3 Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Nuclear Medicine-Radiopharmaceuticals Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine-Radiopharmaceuticals by Major Types

      • 3.4.1 Market Size and Growth Rate of Diagnostic Medicine

      • 3.4.2 Market Size and Growth Rate of Therapeutic Medicine


    4 Segmentation of Nuclear Medicine-Radiopharmaceuticals Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine-Radiopharmaceuticals by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Nuclear Medicine-Radiopharmaceuticals in SPECT

      • 4.4.2 Market Size and Growth Rate of Nuclear Medicine-Radiopharmaceuticals in PET

      • 4.4.3 Market Size and Growth Rate of Nuclear Medicine-Radiopharmaceuticals in Therapeutic


    5 Market Analysis by Regions

    • 5.1 Japan Nuclear Medicine-Radiopharmaceuticals Production Analysis by Regions

    • 5.2 Japan Nuclear Medicine-Radiopharmaceuticals Consumption Analysis by Regions


    6 Hokkaido Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 6.1 Hokkaido Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 6.2 Hokkaido Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    7 Tohoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 7.1 Tohoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 7.2 Tohoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    8 Kanto Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 8.1 Kanto Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 8.2 Kanto Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    9 Chubu Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 9.1 Chubu Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 9.2 Chubu Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    10 Kinki Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 10.1 Kinki Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 10.2 Kinki Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    11 Chugoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 11.1 Chugoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 11.2 Chugoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    12 Shikoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 12.1 Shikoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 12.2 Shikoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    13 Kyushu Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 13.1 Kyushu Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 13.2 Kyushu Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Immunomedics, Inc. (US)

      • 14.1.1 Immunomedics, Inc. (US) Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Mallinckrodt Pharmaceuticals (Ireland)

      • 14.2.1 Mallinckrodt Pharmaceuticals (Ireland) Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Cardinal Health, Inc (US)

      • 14.3.1 Cardinal Health, Inc (US) Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Peregrine Pharmaceuticals, Inc. (US)

      • 14.4.1 Peregrine Pharmaceuticals, Inc. (US) Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Avid Radiopharmaceuticals (US)

      • 14.5.1 Avid Radiopharmaceuticals (US) Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Advanced Medical Isotope Corporation (US)

      • 14.6.1 Advanced Medical Isotope Corporation (US) Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Alseres Pharmaceuticals, Inc (US)

      • 14.7.1 Alseres Pharmaceuticals, Inc (US) Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Bracco Imaging S.p.A (Italy)

      • 14.8.1 Bracco Imaging S.p.A (Italy) Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Bayer HealthCare Medical Care (US)

      • 14.9.1 Bayer HealthCare Medical Care (US) Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Ion Beam Applications S.A (Belgium)

      • 14.10.1 Ion Beam Applications S.A (Belgium) Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 GE Healthcare (UK)

      • 14.11.1 GE Healthcare (UK) Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Siemens Healthcare (US)

      • 14.12.1 Siemens Healthcare (US) Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Jubilant Pharma (India)

      • 14.13.1 Jubilant Pharma (India) Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 Triad Isotopes, Inc. (US)

      • 14.14.1 Triad Isotopes, Inc. (US) Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

    • 14.15 Alliance Medical (UK)

      • 14.15.1 Alliance Medical (UK) Company Profile and Recent Development

      • 14.15.2 Market Performance

      • 14.15.3 Product and Service Introduction

    • 14.16 Nordion, Inc. (Canada)

      • 14.16.1 Nordion, Inc. (Canada) Company Profile and Recent Development

      • 14.16.2 Market Performance

      • 14.16.3 Product and Service Introduction

    • 14.17 Actinium Pharmaceuticals Inc (US)

      • 14.17.1 Actinium Pharmaceuticals Inc (US) Company Profile and Recent Development

      • 14.17.2 Market Performance

      • 14.17.3 Product and Service Introduction

    • 14.18 Positron Corporation (US)

      • 14.18.1 Positron Corporation (US) Company Profile and Recent Development

      • 14.18.2 Market Performance

      • 14.18.3 Product and Service Introduction

    • 14.19 Medi-Radiopharma Ltd (Hungary)

      • 14.19.1 Medi-Radiopharma Ltd (Hungary) Company Profile and Recent Development

      • 14.19.2 Market Performance

      • 14.19.3 Product and Service Introduction

    • 14.20 Lantheus Medical Imaging Inc (US)

      • 14.20.1 Lantheus Medical Imaging Inc (US) Company Profile and Recent Development

      • 14.20.2 Market Performance

      • 14.20.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 98 Figures and 174 Tables)

     

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Medicine from 2014 to 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Medicine from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of SPECT from 2014 to 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of PET from 2014 to 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine-Radiopharmaceuticals Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Nuclear Medicine-Radiopharmaceuticals

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine-Radiopharmaceuticals by Different Types from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine-Radiopharmaceuticals by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Diagnostic Medicine

    • Figure Market Size and Growth Rate of Therapeutic Medicine

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Nuclear Medicine-Radiopharmaceuticals by Different End-Users from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine-Radiopharmaceuticals by Different End-Users from 2014 to 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of SPECT from 2014 to 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of PET from 2014 to 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • Table Japan Nuclear Medicine-Radiopharmaceuticals Production by Regions

    • Table Japan Nuclear Medicine-Radiopharmaceuticals Production Share by Regions

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Production Share by Regions in 2014

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Production Share by Regions in 2018

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Production Share by Regions in 2026

    • Table Japan Nuclear Medicine-Radiopharmaceuticals Consumption by Regions

    • Table Japan Nuclear Medicine-Radiopharmaceuticals Consumption Share by Regions

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Consumption Share by Regions in 2014

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Consumption Share by Regions in 2018

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Consumption Share by Regions in 2026

    • Table Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Kanto Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Kanto Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Chubu Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Chubu Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Kinki Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Kinki Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Immunomedics, Inc. (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics, Inc. (US)

    • Figure Sales and Growth Rate Analysis of Immunomedics, Inc. (US)

    • Figure Revenue and Market Share Analysis of Immunomedics, Inc. (US)

    • Table Product and Service Introduction of Immunomedics, Inc. (US)

    • Table Company Profile and Development Status of Mallinckrodt Pharmaceuticals (Ireland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt Pharmaceuticals (Ireland)

    • Figure Sales and Growth Rate Analysis of Mallinckrodt Pharmaceuticals (Ireland)

    • Figure Revenue and Market Share Analysis of Mallinckrodt Pharmaceuticals (Ireland)

    • Table Product and Service Introduction of Mallinckrodt Pharmaceuticals (Ireland)

    • Table Company Profile and Development Status of Cardinal Health, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cardinal Health, Inc (US)

    • Figure Sales and Growth Rate Analysis of Cardinal Health, Inc (US)

    • Figure Revenue and Market Share Analysis of Cardinal Health, Inc (US)

    • Table Product and Service Introduction of Cardinal Health, Inc (US)

    • Table Company Profile and Development Status of Peregrine Pharmaceuticals, Inc. (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Peregrine Pharmaceuticals, Inc. (US)

    • Figure Sales and Growth Rate Analysis of Peregrine Pharmaceuticals, Inc. (US)

    • Figure Revenue and Market Share Analysis of Peregrine Pharmaceuticals, Inc. (US)

    • Table Product and Service Introduction of Peregrine Pharmaceuticals, Inc. (US)

    • Table Company Profile and Development Status of Avid Radiopharmaceuticals (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Avid Radiopharmaceuticals (US)

    • Figure Sales and Growth Rate Analysis of Avid Radiopharmaceuticals (US)

    • Figure Revenue and Market Share Analysis of Avid Radiopharmaceuticals (US)

    • Table Product and Service Introduction of Avid Radiopharmaceuticals (US)

    • Table Company Profile and Development Status of Advanced Medical Isotope Corporation (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Medical Isotope Corporation (US)

    • Figure Sales and Growth Rate Analysis of Advanced Medical Isotope Corporation (US)

    • Figure Revenue and Market Share Analysis of Advanced Medical Isotope Corporation (US)

    • Table Product and Service Introduction of Advanced Medical Isotope Corporation (US)

    • Table Company Profile and Development Status of Alseres Pharmaceuticals, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alseres Pharmaceuticals, Inc (US)

    • Figure Sales and Growth Rate Analysis of Alseres Pharmaceuticals, Inc (US)

    • Figure Revenue and Market Share Analysis of Alseres Pharmaceuticals, Inc (US)

    • Table Product and Service Introduction of Alseres Pharmaceuticals, Inc (US)

    • Table Company Profile and Development Status of Bracco Imaging S.p.A (Italy)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging S.p.A (Italy)

    • Figure Sales and Growth Rate Analysis of Bracco Imaging S.p.A (Italy)

    • Figure Revenue and Market Share Analysis of Bracco Imaging S.p.A (Italy)

    • Table Product and Service Introduction of Bracco Imaging S.p.A (Italy)

    • Table Company Profile and Development Status of Bayer HealthCare Medical Care (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer HealthCare Medical Care (US)

    • Figure Sales and Growth Rate Analysis of Bayer HealthCare Medical Care (US)

    • Figure Revenue and Market Share Analysis of Bayer HealthCare Medical Care (US)

    • Table Product and Service Introduction of Bayer HealthCare Medical Care (US)

    • Table Company Profile and Development Status of Ion Beam Applications S.A (Belgium)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ion Beam Applications S.A (Belgium)

    • Figure Sales and Growth Rate Analysis of Ion Beam Applications S.A (Belgium)

    • Figure Revenue and Market Share Analysis of Ion Beam Applications S.A (Belgium)

    • Table Product and Service Introduction of Ion Beam Applications S.A (Belgium)

    • Table Company Profile and Development Status of GE Healthcare (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare (UK)

    • Figure Sales and Growth Rate Analysis of GE Healthcare (UK)

    • Figure Revenue and Market Share Analysis of GE Healthcare (UK)

    • Table Product and Service Introduction of GE Healthcare (UK)

    • Table Company Profile and Development Status of Siemens Healthcare (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare (US)

    • Figure Sales and Growth Rate Analysis of Siemens Healthcare (US)

    • Figure Revenue and Market Share Analysis of Siemens Healthcare (US)

    • Table Product and Service Introduction of Siemens Healthcare (US)

    • Table Company Profile and Development Status of Jubilant Pharma (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma (India)

    • Figure Sales and Growth Rate Analysis of Jubilant Pharma (India)

    • Figure Revenue and Market Share Analysis of Jubilant Pharma (India)

    • Table Product and Service Introduction of Jubilant Pharma (India)

    • Table Company Profile and Development Status of Triad Isotopes, Inc. (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes, Inc. (US)

    • Figure Sales and Growth Rate Analysis of Triad Isotopes, Inc. (US)

    • Figure Revenue and Market Share Analysis of Triad Isotopes, Inc. (US)

    • Table Product and Service Introduction of Triad Isotopes, Inc. (US)

    • Table Company Profile and Development Status of Alliance Medical (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alliance Medical (UK)

    • Figure Sales and Growth Rate Analysis of Alliance Medical (UK)

    • Figure Revenue and Market Share Analysis of Alliance Medical (UK)

    • Table Product and Service Introduction of Alliance Medical (UK)

    • Table Company Profile and Development Status of Nordion, Inc. (Canada)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion, Inc. (Canada)

    • Figure Sales and Growth Rate Analysis of Nordion, Inc. (Canada)

    • Figure Revenue and Market Share Analysis of Nordion, Inc. (Canada)

    • Table Product and Service Introduction of Nordion, Inc. (Canada)

    • Table Company Profile and Development Status of Actinium Pharmaceuticals Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actinium Pharmaceuticals Inc (US)

    • Figure Sales and Growth Rate Analysis of Actinium Pharmaceuticals Inc (US)

    • Figure Revenue and Market Share Analysis of Actinium Pharmaceuticals Inc (US)

    • Table Product and Service Introduction of Actinium Pharmaceuticals Inc (US)

    • Table Company Profile and Development Status of Positron Corporation (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Positron Corporation (US)

    • Figure Sales and Growth Rate Analysis of Positron Corporation (US)

    • Figure Revenue and Market Share Analysis of Positron Corporation (US)

    • Table Product and Service Introduction of Positron Corporation (US)

    • Table Company Profile and Development Status of Medi-Radiopharma Ltd (Hungary)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medi-Radiopharma Ltd (Hungary)

    • Figure Sales and Growth Rate Analysis of Medi-Radiopharma Ltd (Hungary)

    • Figure Revenue and Market Share Analysis of Medi-Radiopharma Ltd (Hungary)

    • Table Product and Service Introduction of Medi-Radiopharma Ltd (Hungary)

    • Table Company Profile and Development Status of Lantheus Medical Imaging Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus Medical Imaging Inc (US)

    • Figure Sales and Growth Rate Analysis of Lantheus Medical Imaging Inc (US)

    • Figure Revenue and Market Share Analysis of Lantheus Medical Imaging Inc (US)

    • Table Product and Service Introduction of Lantheus Medical Imaging Inc (US)

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.